EPO Patents = 1

Forward Citations = 232

Loading Chart...

4 inventors (with patents filed for the assignee):

Jonathan LeBowitz (5 out of 24 patents)

Stephen M Beverley (4 out of 10 patents)

John Maga (1 out of 4 patents)

4. William S Sly (1 out of 8 patents)

5 patents: Sort by Forward Citations

1. 7858576 - Method for targeting lysosomal enzymes (2010-12-28),

2. 7785856 - Acid alpha-glucosidase and fragments thereof (2010-08-31),

3. 7629309 - Targeted therapeutic proteins (2009-12-08),

4. 7560424 - Targeted therapeutic proteins (2009-07-14),

5. 7396811 - Subcellular targeting of therapeutic proteins (2008-07-08),

Company Overview

Zystor Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for rare genetic disorders. With a strong emphasis on research and development, Zystor Therapeutics is committed to advancing treatment options for patients with unmet medical needs. The company's pipeline includes potential treatments for various lysosomal storage disorders and other rare diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#147 in Milwaukee, WI

#1,089 in Wisconsin

#51,620 in US

Milwaukee, WI, United States of America

Zystor Therapeutics, Inc.

Forward Citations = 232

4 inventors:

Jonathan LeBowitz (5 out of 24 patents)

Stephen M Beverley (4 out of 10 patents)

John Maga (1 out of 4 patents)

4. William S Sly (1 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Zystor Therapeutics, Inc.. Retrieved from https://idiyas.com/company/zystor-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]